Eflornithine Treatment of Refractory Pneumocystis carinii Pneumonia in Patients with Acquired Immunodeficiency Syndrome
Authors:
- Thomas M. GilmanTGThomas M. Gilman
- Peter N.R. HeseltinePHPeter N.R. Heseltine
- Om P. SharmaOSOm P. Sharma
- C. Thomas BoylenCBC. Thomas Boylen
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Corticosteroids Prevent Early Deterioration in Patients with Moderately Severe Pneumocystis carinii Pneumonia and the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1990
- Are Corticosteroids Beneficial as Adjunctive Therapy for Pneumocystis Pneumonia in AIDS?Annals of Internal Medicine, 1990
- Pneumocystis carinii Pneumonia: DiagnosisThe Journal of Infectious Diseases, 1988
- Prognostic Factors and Life Expectancy of Patients with Acquired Immunodeficiency Syndrome and Pneumocystis carinii PneumoniaAmerican Review of Respiratory Disease, 1987
- Trimethoprim-Sulfamethoxazole or Pentamidine for Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1986
- Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other ImmunodeficienciesAnnals of Internal Medicine, 1984
- Chemotherapeutic implications of polyamine biosynthesis inhibitionClinical Pharmacology & Therapeutics, 1984
- Polyamine metabolism and functionAmerican Journal of Physiology-Cell Physiology, 1982
- Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogsJournal of the American Chemical Society, 1978
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976